BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical
company focused on helping people live healthier longer through the development and commercialization of novel therapeutics for the
treatment of aging-related diseases, today announced that company management will present a corporate overview at three investor
conferences in November:
Credit Suisse 27th Annual Healthcare Conference
Date: Wednesday, November 14, 2018
Time: 4:00 p.m. MT (6:00 p.m. ET)
Location: Scottsdale, AZ
30th Annual Piper Jaffray Healthcare Conference
Date: Tuesday, November 27, 2018
Time: 1:30 p.m. ET
Location: New York, NY
Evercore ISI HealthconX
Date: Wednesday, November 28, 2018
Time: 2:45 p.m. ET
Location: Boston, MA
A live audio webcast of each presentation can be accessed on the Investors section of resTORbio’s website at http://ir.restorbio.com/investors. Archived replays of each presentation will be available for
at least 30 days following the presentation.
About resTORbio
resTORbio, Inc. is a clinical stage biopharmaceutical company targeting TORC1 and other biological pathways that regulate aging to
develop innovative medicines with the potential to extend healthy lifespan. resTORbio’s lead program is selectively targeting
TORC1, an evolutionarily conserved pathway that contributes to the decline in function of multiple organ systems, including the
immune, cardiovascular and central nervous systems. For more information, visit https://www.restorbio.com/.
Investor Contact:
Jennifer Robinson
resTORbio, Inc.
857-772-7029
jrobinson@restorbio.com
Media Contact:
Christopher Hippolyte
Biosector 2
212-364-0458
christopher.hippolyte@syneoshealth.com
